High Cholesterol Study
High Cholesterol Trials in Columbus
Aventiv Research is currently participating in a dyslipidemia study at our Columbus, Ohio location.
The purpose of this study is to investigate whether obicetrapib (an investigational drug) taken in combination with ezetimibe (an FDA-approved drug) as a standalone therapy, is effective for potentially treating people with dyslipidemia when compared to placebo with high-intensity statin therapy.
You may be eligible to participate if you:
- Are 18 – 75 years of age
- Have fasting LDL-C levels >70 mg/dL, and TG levels <375 mg/dL
- Are currently receiving high-intensity statin therapy
- Other requirements may apply
Ready to Volunteer?
Volunteer today to see if you qualify for our high cholesterol clinical research study. Qualified volunteers will be compensated for time and travel.